المؤلفون: Ashina, Messoud, Goadsby, Peter J., Reuter, Uwe, Silberstein, Stephen, Dodick, David, Rippon, Gregory A., Klatt, Jan, Xue, Fei, Chia, Victoria, Zhang, Feng, Cheng, Sunfa, Mikol, Daniel D.

المصدر: Ashina , M , Goadsby , P J , Reuter , U , Silberstein , S , Dodick , D , Rippon , G A , Klatt , J , Xue , F , Chia , V , Zhang , F , Cheng , S & Mikol , D D 2019 , ' Long-term safety and tolerability of erenumab : Three-plus year results from a five-year open-label extension study in episodic migraine ' , Cephalalgia , vol. 39 , no. 11 , pp. 1455-1464 . https://doi.org/10.1177/0333102419854082Test

مصطلحات موضوعية: Erenumab, migraine, safety

الإتاحة: https://doi.org/10.1177/0333102419854082Test
https://kclpure.kcl.ac.uk/portal/en/publications/c607d7a4-8b4b-4583-8a1e-35e42fc730bcTest
http://www.scopus.com/inward/record.url?scp=85066834325&partnerID=8YFLogxKTest

المؤلفون: Lampl, Christian, Kraus, Viktoria, Lehner, Katrina, Loop, Brett, Chehrenama, Mahan, Maczynska, Zofia, Ritter, Shannon, Klatt, Jan, Snellman, Josefin

المصدر: Journal of Headache & Pain; 8/18/2022, Vol. 23 Issue 1, p1-19, 19p

مصطلحات موضوعية: MIGRAINE prevention, THERAPEUTIC use of monoclonal antibodies, DRUG tolerance, CHRONIC diseases, ANALGESICS, MIGRAINE, AGE distribution, MONOCLONAL antibodies, PLACEBOS, TREATMENT effectiveness, DESCRIPTIVE statistics, PATIENT safety, SYMPTOMS, EVALUATION, OLD age

المؤلفون: Ashina, Messoud, Kudrow, David, Reuter, Uwe, Dolezil, David, Silberstein, Stephen, Tepper, Stewart J., Xue, Fei, Picard, Hernan, Zhang, Feng, Wang, Andrea, Zhou, Yanchen, Hong, Frank, Klatt, Jan, Mikol, Daniel D.

المصدر: Ashina , M , Kudrow , D , Reuter , U , Dolezil , D , Silberstein , S , Tepper , S J , Xue , F , Picard , H , Zhang , F , Wang , A , Zhou , Y , Hong , F , Klatt , J & Mikol , D D 2019 , ' Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine : A pooled analysis of four placebo-controlled trials with long-term extensions ' , Cephalalgia , vol. 39 , no. 14 , ....

مصطلحات موضوعية: Erenumab, migraine, safety

الإتاحة: https://doi.org/10.1177/0333102419888222Test
https://curis.ku.dk/portal/da/publications/longterm-tolerability-and-nonvascularTest-safety-of-erenumab-a-novel-calcitonin-generelated-peptide-receptor-antagonist-for-prevention-of-migraine(5d0cfd1d-4304-4ea0-b94a-6d2649fdeee2).html